Comparing like with like: some historical milestones in the evolution of methods to create unbiased comparison groups in therapeutic experiments

被引:57
作者
Chalmers, I [1 ]
机构
[1] UK Cochrane Ctr, NHS Res & Dev Programme, Oxford OX2 7LG, England
关键词
D O I
10.1093/ije/30.5.1156
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Histories of clinical trials have recorded and analysed the development of quantification in therapeutic evaluation, the emergence of probabilistic thinking, the application of statistical methods and theory, and the sociology, ethics and politics of clinical trials; but it is surprising that they only rarely identify as a distinct theme the development of efforts to control biases. An exception is Kaptchuk's recent account of the history of blinding and placebos for reducing observer biases. In this complementary paper I introduce and discuss some milestones between 1662 and 1948 in the development of methods to control selection biases when assembling therapeutic comparison groups, to ensure, as far as possible, that 'like is compared with like'. In the paper I note (i) that treatment allocation based on strict alternation abolishes selection bias as effectively as treatment allocation based on strict random allocation; (ii) that use of schedules based on random numbers is more likely to prevent foreknowledge of allocation schedules, and thus the risk of introducing selection bias at the point of recruitment to trials; (iii) that a concern to conceal allocation schedules was the rationale for using schedules based on random numbers in the Medical Research Council trials of vaccination for whooping cough and streptomycin for pulmonary tuberculosis; and (iv) that the introduction of allocation concealment more than half a century ago remains the most recent substantive milestone in the history of efforts to control selection biases in therapeutic experiments.
引用
收藏
页码:1156 / 1164
页数:9
相关论文
共 56 条
[1]  
Altman DG, 1999, BRIT MED J, V318, P1209
[2]  
ALTMAN DG, IN PRESS BR MED J
[3]  
Amberson JB., 1931, AM REV TUBERC, V24, P401
[4]  
[Anonymous], 1951, Br Med J, V1, P1463
[5]  
[Anonymous], 1948, BMJ, V2, P769, DOI [10.1136/bmj.2.4582.769, DOI 10.1136/BMJ.2.4582.769]
[6]  
ARMITAGE P, 2001, CONTROLLED TRIALS HI
[7]  
ATKINS W. R. G., 1944, Journal of the Royal Army Medical Corps, V83, P251
[8]  
Balfour TG, 1854, LECT DIS INFANCY CHI, P600
[9]   Improving the quality of reporting of randomized controlled trials - The CONSORT statement [J].
Begg, C ;
Cho, M ;
Eastwood, S ;
Horton, R ;
Moher, D ;
Olkin, I ;
Pitkin, R ;
Rennie, D ;
Schulz, KF ;
Simel, D ;
Stroup, DF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (08) :637-639
[10]  
BINGEL A, 1918, DTSCH ARCH KLIN MED, V125, P284